Asia · Mercados regionales · Korea Economic Daily
Alteogen clears US patent hurdle as Merck wins all 14 challenges vs Halozyme

Resumen detallado
South Korea's Alteogen Inc. has cleared a major US patent hurdle after its partner Merck & Co. prevailed in all 14 challenges against rival Halozyme Therap ...
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.kedglobal.com)



